Výsledky vyhledávání - "Emaryn Mancino"

A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma

Autor: Hanlon Sia, Peter T. Tan, Joshua Richter, Phoebe Joy Ho, Tara Cochrane, Hang Quach, Binod Dhakal, Igor Proscurshim, Tony Jiang, Emaryn Mancino, Yacine Salhi, Sammicheli Stefano, Girish Gudi, Andrew Garton, Eric J. Feldman, Andrew Spencer

Publikováno v: Blood. 140:10182-10184

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2c069696ee82ef8c93e495e3908c274
https://doi.org/10.1182/blood-2022-157585

Zobrazit plný text záznamu

Final Safety and Efficacy Results from the CPX-351 Early Access Program (EAP) for Older Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML)

Autor: Michael Chiarella, Emaryn Mancino, Tara L. Lin, S. Eric Rubenstein, Scott R. Solomon, Gail J. Roboz, Gary J. Schiller, Arthur C. Louie, Melissa L. Larson, Qi An

Publikováno v: Blood. 132:1434-1434

Background: CPX-351 (Vyxeos®) is a dual-drug liposomal encapsulation of cytarabine and daunorubicin at a synergistic ratio. In a large randomized, open-label, multicenter, phase 3 study of CPX-351 versus conventional cytarabine/daunorubicin chemothe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7728589e7ba5162984abd7ae73a8b6b1
https://doi.org/10.1182/blood-2018-99-111537

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání